PARITAPREVIR | PARITAPREVIR | ATC J05AP52 ATC J05AP53
ANTIINFECTIVES TREATMENT OF GENOTYPE 1 CHRONIC HEPATITIS C VIRUS (HCV) HEPATITIS C VIRUS NS3/4A PROTEASE INHIBITOR | ORAL | Cmax 342.4 NANOMOLAR Tmax 4.5 HOUR VD 16.7 LITER PPB 97.8 PERCENT Cl 2.1 LITER / HOUR (EQN) HT 5.5 HOUR SOLUBILITY VERY LOW WATER SOLUBILITY | HCV NS3/4A PROTEASE | HEPATITIS C VIRUS SERINE PROTEASE, NS3/NS4A INHIBITOR CHEMBL2095231 HEPATITIS C VIRUS SERINE PROTEASE, NS3/NS4A A3EZI9 NS3 HEPATITIS C VIRUS ENZYME PROTEASE SERINE PAS S29 | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |